Drug intelligence / Profile preview

Nitric oxide + oxygen

Development stage
Unknown
Lead developer
Ikaria
Modality
Small Molecules
Administration
Inhalation
01

Overview

Nitric oxide + oxygen refers to the therapeutic administration of inhaled nitric oxide gas, typically delivered in combination with oxygen via a ventilator or breathing circuit. Nitric oxide acts as a selective pulmonary vasodilator by relaxing smooth muscle cells in the pulmonary vasculature, leading to improved blood flow and oxygenation in ventilated areas of the lung. This therapy is primarily used for treating hypoxic respiratory failure and persistent pulmonary hypertension in term and near-term neonates, but it is also used off-label for acute respiratory distress syndrome (ARDS) and other forms of pulmonary hypertension in adults and children. The mechanism involves rapid binding of inhaled nitric oxide to oxyhemoglobin, which limits its effects to well-ventilated lung regions[1][2][3][4][5][8]. Inhaled nitric oxide may also have anti-inflammatory properties and can reduce afterload on the heart[6].

Brand names
INOmax
Other names
Nitric Oxide for inhalation plus oxygeniNO + O2
02

Targets

sGC (Soluble Guanylyl Cyclase)

Beyond the preview

Go deeper on Nitric oxide + oxygen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nitric oxide + oxygen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call